In vitro endothelialization of cobalt chromium alloys with micro/nanostructures using adipose-derived stem cells

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 4, 2013, Pages 1067-1077

  Shi, Zhilong ^a   Neoh, K G ^a   Kang, E T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED STEM CELLS; COBALT-CHROMIUM ALLOYS; ENDOTHELIAL DIFFERENTIATION; MICRO/NANOSTRUCTURES; MICROSTRUCTURED SUBSTRATES; NANOSTRUCTURED SUBSTRATES; NANOSTRUCTURED SURFACE; QUANTITATIVE REAL TIME PCR;

CHROMIUM ALLOYS; COBALT; POLYMERASE CHAIN REACTION; STEM CELLS;

SUBSTRATES;

CHROMIUM DERIVATIVE; COBALT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTEGRIN; NANOMATERIAL; VITRONECTIN; VON WILLEBRAND FACTOR;

ADIPOSE DERIVED STEM CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; PIRANHA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ADSORPTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMIUM ALLOYS; ENDOTHELIUM, VASCULAR; HUMANS; MICROSCOPY, ELECTRON, SCANNING; NANOSTRUCTURES; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84876289536     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-4868-7     Document Type: Article

References (55)

1. Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol. 2010;56(10 Suppl):S1-42.
2. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007;356(10):1009-19.
3. Koren B, Weisz A, Fischer L, Gluzman Z, Preis M, Avramovitch N, Cohen T, Cosset FL, Lewis BS, Flugelman MY. Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor. Cardiovasc Revasc Med. 2006;7(3):173-8.
4. Achneck HE, Jamiolkowski RM, Jantzen AE, Haseltine JM, Lane WO, Huang JK, Galinat LJ, Serpe MJ, Lin FH, Li M, et al. The biocompatibility of titanium cardiovascular devices seeded with autologous blood-derived endothelial progenitor cells: EPC-seeded antithrombotic Ti implants. Biomaterials. 2011;32(1):10-8.
5. Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation. 1989;80(5):1347-53.
6. Parikh SA, Edelman ER. Endothelial cell delivery for cardiovascular therapy. Adv Drug Deliv Rev. 2000;42(1-2):139-61.
7. Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res. 2007;100(2):174-90.
8. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101-9.
9. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249-60.
10. Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumie A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004;110(3):349-55.
11. Martinez-Estrada OM, Munoz-Santos Y, Julve J, Reina M, Vilaro S. Human adipose tissue as a source of Flk-1(+) cells: new method of differentiation and expansion. Cardiovasc Res. 2005;65(2):328-33.
12. DiMuzio P, Tulenko T. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells. J Vasc Surg. 2007;45(Suppl A):A99-103.
13. Lord MS, Foss M, Besenbacher F. Influence of nanoscale surface topography on protein adsorption and cellular response. Nano Today. 2010;5(1):66-78.
14. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 2005;310(5751):1135-8.
15. McMurray RJ, Gadegaard N, Tsimbouri PM, Burgess KV, McNamara LE, Tare R, Murawski K, Kingham E, Oreffo RO, Dalby MJ. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat Mater. 2011;10(8):637-44.
16. Brunetti V, Maiorano G, Rizzello L, Sorce B, Sabella S, Cingolani R, Pompa PP. Neurons sense nanoscale roughness with nanometer sensitivity. Proc Natl Acad Sci USA. 2010;107(14):6264-9.
17. Liu XY, Chu PK, Ding CX. Surface nano-functionalization of biomaterials. Mater Sci Eng, R. 2010;70(3-6):275-302.
18. Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P, Wilkinson CD, Oreffo RO. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater. 2007;6(12):997-1003.
19. Yim EK, Pang SW, Leong KW. Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res. 2007;313(9):1820-9.
20. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky AJ. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol. 2003;92(4):463-6.
21. Scott NA, Candal FJ, Robinson KA, Ades EW. Seeding of intracoronary stents with immortalized human microvascular endothelial cells. Am Heart J. 1995;129(5):860-6.
22. Vetrone F, Variola F, Tambasco de Oliveira P, Zalzal SF, Yi JH, Sam J, Bombonato-Prado KF, Sarkissian A, Perepichka DF, Wuest JD, et al. Nanoscale oxidative patterning of metallic surfaces to modulate cell activity and fate. Nano Lett. 2009;9(2):659-65.
23. Poh CK, Shi Z, Lim TY, Neoh KG, Wang W. The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials. 2010;31(7):1578-85.
24. Garcia AJ, Vega MD, Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol Biol Cell. 1999;10(3):785-98.
25. Shi Z, Neoh KG, Kang ET, Poh CK, Wang W. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration. Biomacromolecules. 2009;10(6):1603-11.
26. T method. Nat Protoc. 2008;3(6):1101-8.
27. Horbett TA. The role of adsorbed proteins in animal-cell adhesion. Colloids Surf B. 1994;2(1-3):225-40.
28. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng. 2005;11(1-2):1-18.
29. Barrias CC, Martins MC, Almeida-Porada G, Barbosa MA, Granja PL. The correlation between the adsorption of adhesive proteins and cell behaviour on hydroxyl-methyl mixed self-assembled monolayers. Biomaterials. 2009;30(3):307-16.
30. Kilpadi KL, Chang PL, Bellis SL. Hydroxylapatite binds more serum proteins, purified integrins, and osteoblast precursor cells than titanium or steel. J Biomed Mater Res. 2001;57(2):258-67.
31. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res. 2000;51(3):475-83.
32. Steele JG, Dalton BA, Johnson G, Underwood PA. Polystyrene chemistry affects vitronectin activity: an explanation for cell attachment to tissue culture polystyrene but not to unmodified polystyrene. J Biomed Mater Res. 1993;27(7):927-40.
33. Lutolf MP, Gilbert PM, Blau HM. Designing materials to direct stem-cell fate. Nature. 2009;462(7272):433-41.
34. Curtis AS, Gadegaard N, Dalby MJ, Riehle MO, Wilkinson CD, Aitchison G. Cells react to nanoscale order and symmetry in their surroundings. IEEE Trans Nanobiosci. 2004;3(1):61-5.
35. Bettinger CJ, Langer R, Borenstein JT. Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl. 2009;48(30):5406-15.
36. Kruss S, Wolfram T, Martin R, Neubauer S, Kessler H, Spatz JP. Stimulation of cell adhesion at nanostructured teflon interfaces. Adv Mater. 2010;22(48):5499-506.
37. Pennisi CP, Dolatshahi-Pirouz A, Foss M, Chevallier J, Fink T, Zachar V, Besenbacher F, Yoshida K. Nanoscale topography reduces fibroblast growth, focal adhesion size and migration-related gene expression on platinum surfaces. Colloids Surf B. 2011;85(2):189-97.
38. Shi X, Nakagawa M, Kawachi G, Xu L, Ishikawa K. Surface modification of titanium by hydrothermal treatment in Mg-containing solution and early osteoblast responses. J Mater Sci Mater Med. 2012;23(5):1281-90.
39. Pegueroles M, Aguirre A, Engel E, Pavon G, Gil FJ, Planell JA, Migonney V, Aparicio C. Effect of blasting treatment and Fn coating on MG63 adhesion and differentiation on titanium: a gene expression study using real-time RT-PCR. J Mater Sci Mater Med. 2011;22(3):617-27.
40. Docheva D, Popov C, Mutschler W, Schieker M. Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system. J Cell Mol Med. 2007;11(1):21-38.
41. Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 1999;18(4):882-92.
42. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028-32.
43. Oh S, Brammer KS, Li YS, Teng D, Engler AJ, Chien S, Jin S. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci USA. 2009;106(7):2130-5.
44. Sales KM, Salacinski HJ, Alobaid N, Mikhail M, Balakrishnan V, Seifalian AM. Advancing vascular tissue engineering: the role of stem cell technology. Trends Biotechnol. 2005;23(9):461-7.
45. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109(13):1615-22.
46. Albelda SM, Muller WA, Buck CA, Newman PJ. Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol. 1991;114(5):1059-68.
47. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593-615.
48. de Mel A, Murad F, Seifalian AM. Nitric oxide: a guardian for vascular grafts? Chem Rev. 2011;111(9):5742-67.
49. Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173-206.
50. Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res. 1992;70(2):348-54.
51. Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials. 2003;24(13):2295- 302.
52. Calvert PA, Bennett MR. Restenosis revisited. Circ Res. 2009;104(7):823-5.
53. Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 2011;75(6):1287-96.
54. Wessely R. New drug-eluting stent concepts. Nat Rev Cardiol. 2010;7(4):194-203.
55. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation. 2003;108(14):1701-6.